Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study (PLoS One (2017) 12:9 (e0184550) DOI: 10.1371/journal.pone.0184550)
- Buti, M.
- Manzano, M.L.
- Morillas, R.M.
- García-Retortillo, M.
- Martín, L.
- Prieto, M.
- Gutiérrez, M.L.
- Suárez, E.
- Gómez Rubio, M.
- López, J.
- Castillo, P.
- Rodríguez, M.
- Zozaya, J.M.
- Simón, M.A.
- Morano, L.E.
- Calleja, J.L.
- Yébenes, M.
- Esteban, R.
Zeitschrift:
PLoS ONE
ISSN: 1932-6203
Datum der Publikation: 2018
Ausgabe: 13
Nummer: 6
Art: Erratum